English appeals court refuses Neurim injunction for insomnia drug
26-06-2020
Teva to face inhaler infringement allegations in UK court
03-06-2020
Partial win for Mylan as Fed Circuit cancels Boehringer patents
17-03-2020
ricochet64 / Shutterstock.com
In a victory for Mylan, the English High Court has rejected Israel-based pharmaceutical company Neurim’s attempt to delay a generic version of its insomnia medication.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
English High Court, Mylan, Neurim, generic, injunction, insomnia, patent infringement, Circadin
